Adenoid  	Adenoid  	 JJ	B-NP
hypetrophy 	hypetrophy 	 NN	I-NP
:  	:  	 :	O
definition  	definition  	 NN	O
of  	of  	 IN	O
some  	some  	 DT	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
Adenoids  	Adenoids  	 RB	O
removed  	removed  	 VBN	O
for  	for  	 IN	O
airway  	airway  	 JJ	B-NP
obstruction  	obstruction  	 NN	I-NP
and-or  	and-or  	 JJ	I-NP
recurrent  	recurrent  	 JJ	O
infections  	infections  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
studied  	studied  	 VBN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
a  	a  	 DT	O
possible  	possible  	 JJ	O
mechanism  	mechanism  	 NN	O
to  	to  	 TO	O
explain  	explain  	 VB	O
chronicity 	chronicity 	 NNS	B-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
regard 	regard 	 NN	O
,  	,  	 ,	O
macrophages  	macrophages  	 NNS	B-NP
may  	may  	 MD	O
play  	play  	 VB	O
a  	a  	 DT	O
relevant  	relevant  	 JJ	O
pathogenic  	pathogenic  	 JJ	B-NP
role  	role  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
neutrophils  	neutrophils  	 NN	B-NP
during  	during  	 IN	O
bacterial  	bacterial  	 JJ	B-NP
infections  	infections  	 NNS	I-NP
and  	and  	 CC	O
eosinophils  	eosinophils  	 NN	B-NP
in  	in  	 IN	O
allergic  	allergic  	 JJ	B-NP
inflammation 	inflammation 	 NN	I-NP
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
study  	study  	 NN	O
aimed  	aimed  	 VBN	O
at  	at  	 IN	O
investigating  	investigating  	 VBG	O
some  	some  	 DT	O
mediators  	mediators  	 NN	O
as  	as  	 IN	O
surrogate  	surrogate  	 JJ	O
markers  	markers  	 NN	O
of  	of  	 IN	O
inflammation  	inflammation  	 NN	B-NP
in  	in  	 IN	O
children  	children  	 NNS	O
who  	who  	 WP	O
had  	had  	 VBD	O
to  	to  	 TO	O
undergo  	undergo  	 VB	O
to  	to  	 TO	O
adenoidectomy 	adenoidectomy 	 VB	O
.  	.  	 .	O
Globally 	Globally 	 RB	O
,  	,  	 ,	O
67  	67  	 CD	O
children  	children  	 NNS	O
( 	( 	 -LRB-	O
25  	25  	 CD	O
females 	females 	 NNS	O
,  	,  	 ,	O
42  	42  	 CD	O
males 	males 	 NNS	O
,  	,  	 ,	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
4.9  	4.9  	 CD	O
years 	years 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
persistent  	persistent  	 JJ	O
obstruction  	obstruction  	 NN	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
adenoid  	adenoid  	 JJ	B-NP
hypertrophy  	hypertrophy  	 NN	I-NP
were  	were  	 VBD	O
consecutively  	consecutively  	 JJ	O
enrolled  	enrolled  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Blood  	Blood  	 NN	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
controls  	controls  	 NNS	O
to  	to  	 TO	O
determine  	determine  	 VB	O
serum  	serum  	 JJ	B-NP
CD163 	CD163 	 NN	I-NP
,  	,  	 ,	O
Myeloperoxidase  	Myeloperoxidase  	 NNP	B-NP
( 	( 	 -LRB-	O
MPO 	MPO 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
ECP 	ECP 	 NNP	B-NP
.  	.  	 .	O
There  	There  	 EX	O
were  	were  	 VBD	O
significant  	significant  	 JJ	O
differences  	differences  	 NNS	O
between  	between  	 IN	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
controls  	controls  	 NNS	O
for  	for  	 IN	O
serum  	serum  	 CD	B-NP
CD163  	CD163  	 CD	I-NP
( 	( 	 -LRB-	O
p  	p  	 RB	O
less  	less  	 JJR	O
than  	than  	 IN	O
0.0001 	0.0001 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
MPO  	MPO  	 NNP	B-NP
( 	( 	 -LRB-	O
p  	p  	 RB	O
less  	less  	 JJR	O
than  	than  	 IN	O
0.0001 	0.0001 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
serum  	serum  	 JJ	B-NP
ECP  	ECP  	 NNP	I-NP
( 	( 	 -LRB-	O
p  	p  	 RB	O
less  	less  	 JJR	O
than  	than  	 IN	O
0.0001 	0.0001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
demonstrated  	demonstrated  	 VBD	O
some  	some  	 DT	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	O
severe  	severe  	 JJ	O
AH 	AH 	 NNP	B-NP
:  	:  	 :	O
apnoea 	apnoea 	 CD	B-NP
,  	,  	 ,	O
recurrent  	recurrent  	 JJ	O
respiratory  	respiratory  	 JJ	B-NP
infections 	infections 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
high  	high  	 JJ	O
serum  	serum  	 NN	B-NP
CD163  	CD163  	 CD	I-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
